Search clinical trials for: 5-FU and oxaliplatin

Total 8284 results

David Bartlett
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases

Colorectal Liver Metastases

United States
Nanjing Medical University

Unknown

OPTIMOX1 in Chinese mCRC Patients

Colorectal Cancer

China
Oslo University Hospital

Completed

Oxaliplatin and 5-FU Based Preoperative Chemoradiation (LARC-RRP)

Rectal Cancer

Norway
University of Erlangen-Nürnberg Medical School

Completed

Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer

Rectal Neoplasms

Germany
Xu jianmin

Unknown

Intraoperative Intraportal Chemotherapy Combined With Adjuvant Chemotherapy for Stage II and III Colorectal Cancer

Neoplasm Metastasis | Liver Neoplasms | Colorectal Neoplasms

China
Suzhou Transcenta Therapeutics Co., Ltd.

Not yet recruiting

Combination of TST001, Nivolumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma

Gastric Cancer | Advanced Cancer | Gastroesophageal-junction Cancer
University Health Network, Toronto

Completed

A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases

Colorectal Cancer | Liver Metastases

Canada
Peking University Cancer Hospital & Institute

Unknown

Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection (HAICAT)

Hepatocellular Carcinoma

China
Sun Yat-sen University
Guangzhou No.12 People's Hospital; Kaiping Central Hospital

Unknown

Sorafenib or Lenvatinib Plus HAIC of 130 mg/m² Oxaliplatin, and 5-fu vs Sorafenib or Lenvatinib Plus HAIC of 85mg/m² Oxaliplatin, and 5-fu for Unresectable Advanced HCC: a Randomised Phase 3 Trial

Hepatocellular Carcinoma

China
Fundación de investigación HM
Syntax for Science, S.L

Completed

A Study to Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer

Locally Advanced Rectal Cancer (LARC)

Spain
University of Sao Paulo General Hospital
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Impact of Adjuvant Chemotherapy in Patients With Colon Cancer

Colon Cancer | Adjuvant Chemotherapy

Brazil
Ralf Hofheinz
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; Deutsche... and other collaborators

Recruiting

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

Rectal Cancer

Germany
Grupo Hospital de Madrid

Completed

Study of Therapeutic Targets Tailored Ch and IMRT as Neoadjuvant Treatment in Rectal Carcinoma Patients (TT)

Rectal Cancer

Spain
Sixth Affiliated Hospital, Sun Yat-sen University

Unknown

Dose-dense Biweekly Docetaxel, Oxaliplatin and 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer (DaeMon-Plus)

Docetaxel, Oxaliplatin and Fluorouracil

China
Sanofi

Completed

Oxaliplatin in Esophagus Cancer (Advanced) 1st Line

Esophageal Neoplasms

Spain
Sun Yat-sen University

Unknown

Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil

HepatoCellular Carcinoma

China
Federation Francophone de Cancerologie Digestive

Recruiting

Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver (OSCAR)

Colorectal Neoplasms

France, Switzerland
China Meitan General Hospital

Completed

Chemotherapy Combined With CIK Treating Colon Cancer

Postoperative Complications | Colorectal Cancer | Survival | Cytokine-induced Killer Cells
Wakayama Medical University

Completed

Neoadjuvant FIRINOX for Borderline Resectable Pancreatic Cancer - a Pilot Study (FIRINOX)

Patients With Borderline Resectable Pancreatic Cancer

Japan
Sanofi

Completed

Docetaxel and Oxaliplatin in Gastric Cancer

Stomach Neoplasms

France, Russian Federation, Portugal, Spain, United States, Turkey, Belgium, Hungary, Italy, United Kingdom, Germany, Switzerland
Dominik Paul Modest
German Research Foundation; Institut für Klinische Krebsforschung IKF GmbH...

Recruiting

Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)

Colorectal Cancer

Germany
Charite University, Berlin, Germany

Completed

FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer (PaFLO)

Advanced Gastric Cancer

Germany
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Phase II/III Study of HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate and Bevacizumab Versus FOLFOX in Combination With Bevacizumab for First-line Treatment of Advanced Colorectal Cancer

Colorectal Cancer

China
Fudan University

Recruiting

Sintilimab Combined With Modified FLOT Regimen in the Treatment of Metastatic Gastric Cancer

Gastric Cancer | Chemotherapy Effect | Immune Checkpoint Inhibitor

China
Sun Yat-sen University

Unknown

Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer (FOWARC)

Rectal Cancer

China
Hamamatsu University

Completed

Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer

Esophageal Cancer | Squamous Cell Carcinoma

Japan
BeiGene

Completed

BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma

Esophageal Squamous Cell Carcinoma, Gastric Carcinoma, Gastroesophageal Junction Carcinoma

China
Yonsei University

Completed

Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer

Recurrent or Metastatic Gastric Cancer

Korea, Republic of
National Cancer Institute (NCI)

Completed

Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum

Adenocarcinoma of the Rectum | Stage II Rectal Cancer | Stage III Rectal Cancer

United States
Sanofi

Completed

Endometrial Cancer - LOHP Alone and With 5FU

Endometrial Cancer

France
Oslo University Hospital
University Hospital of North Norway; Helse Stavanger HF; Haukeland University... and other collaborators

Active, not recruiting

Nordic Pancreatic Cancer Trial (NorPACT) - 1

Pancreatic Cancer

Sweden, Norway, Denmark, Finland
Bayer
Amgen

Completed

Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects

Metastatic Colorectal Cancer

Belgium, Italy, Poland, Spain, Russian Federation, United States, Hungary, Romania, United Kingdom, Ukraine
NSABP Foundation Inc
Sanofi

Withdrawn

Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal Cancer

Metastatic Colorectal Cancer | Colorectal Cancer
Eli Lilly and Company
ARMO BioSciences

Completed

Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer (Sequoia)

Pancreatic Cancer

United States, Belgium, Spain, Poland, Korea, Republic of, Taiwan, Germany, Italy, France, United Kingdom, Austria, Australia, Canada
Sanofi

Completed

Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck

Head and Neck Cancer

France
University of Cologne
Servier

Recruiting

Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas (HOLIPANC)

Pancreatic Cancer | Surgery | Metastasis | Oligometastatic Disease

Germany
Wuhan University

Completed

Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer

Malignant Neoplasm of Colorectum

China
Fudan University

Recruiting

Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)

Locally Advanced Colorectal Cancer

China
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction

Esophageal Cancer

United States
Eastern Hepatobiliary Surgery Hospital

Completed

Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence

Hepatocellular Carcinoma

China
University of Roma La Sapienza

Not yet recruiting

Proactive Management of Endoperitoneal Spread in Colonic Cancer (PROMENADE)

Colon Cancer | Intraperitoneal Rectal Cancer

Italy
Zhejiang University

Not yet recruiting

Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab (CAPT-02)

Resectable Pancreatic Cancer | Neoadjuvant Chemotherapy
European Organisation for Research and Treatment...
Sanofi

Withdrawn

Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases (BOS3)

Colorectal Cancer Metastatic | Liver Metastases | KRAS Mutated Colorectal Cancer
Taiho Pharmaceutical Co., Ltd.
Yakult Honsha Co., LTD

Completed

Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer

Colorectal Cancer

Japan
William Sikov MD
The Miriam Hospital; Rhode Island Hospital; Memorial Hospital of Rhode Island

Completed

Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)

Rectal Cancer | Colon Cancer

United States
NSABP Foundation Inc
National Cancer Institute (NCI); Cancer and Leukemia Group B

Unknown

Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer

Colorectal Cancer
Institut Cancerologie de l'Ouest

Completed

Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer (PAMELA70)

Toxicity | Pancreatic Metastatic Cancer

France
Technical University of Munich

Completed

Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction (MEMORI)

Adenocarcinoma of the Esophagogastric Junction

Germany
LI XIN-XIANG

Recruiting

Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy

Rectal Neoplasms

China
Sun Yat-sen University

Completed

Neoadjuvant FOLFOXIRI Chemotherapy Alone for Locally Advanced Rectal Cancer (FORTUNE)

Rectal Cancer

China

Search clinical trials for: 5-FU and oxaliplatin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations